AO Pharm-Sintez

AO Pharm-Sintez, established in 1997, operates as a prominent Russian pharmaceutical entity specializing in the comprehensive production cycle of medicinal products. The company manages the entire process from the synthesis of active pharmaceutical ingredients to the final release of finished dosage forms. By maintaining a focus on high-quality manufacturing standards, AO Pharm-Sintez serves critical sectors within the healthcare industry, ensuring that essential medications reach patients through the subsidized drug supply segment. Their technical expertise spans multiple therapeutic areas, including gynecology, surgery, neurology, oncology, endocrinology, theranostics, and urology.

The organization currently maintains a workforce of 500-1,000 employees across 2 operational locations. This scale allows for robust management of their ongoing large-scale manufacturing facility construction project, which aims to expand their production capacity significantly. Meet AO Pharm-Sintez's team to understand the leadership driving these operational advancements and the strategic vision behind their infrastructure investments. The company’s commitment to technical excellence and regulatory compliance remains central to their operational framework, ensuring that all pharmaceutical outputs meet rigorous safety and efficacy standards required for prescription medications in the Russian market.

With an annual revenue of $27.8M, AO Pharm-Sintez continues to solidify its market position as a key provider of specialized prescription drugs. Their product portfolio is diverse, encompassing advanced treatments for complex conditions such as cancer and various chronic diseases. By integrating research and development with large-scale manufacturing, the company effectively addresses the evolving needs of the healthcare sector. Their focus on therapeutic innovation and patient-centric care drives their ongoing growth and competitive presence within theView more...